116 related articles for article (PubMed ID: 11741599)
41. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
[TBL] [Abstract][Full Text] [Related]
42. An unexpected role for FosB in activation-induced cell death of T cells.
Baumann S; Hess J; Eichhorst ST; Krueger A; Angel P; Krammer PH; Kirchhoff S
Oncogene; 2003 Mar; 22(9):1333-9. PubMed ID: 12618758
[TBL] [Abstract][Full Text] [Related]
43. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
[TBL] [Abstract][Full Text] [Related]
44. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
[TBL] [Abstract][Full Text] [Related]
45. [CD95 (APO-1/Fas) and CD95-ligand (CD95L). Implications of these apoptosis mediating receptor/ligand systems in the pathogenesis of autoimmune diseases].
Möller P; von Reyher U; Leithäuser F; Sträter J
Verh Dtsch Ges Pathol; 1996; 80():12-20. PubMed ID: 9064994
[TBL] [Abstract][Full Text] [Related]
46. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
47. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events.
Latinis KM; Carr LL; Peterson EJ; Norian LA; Eliason SL; Koretzky GA
J Immunol; 1997 May; 158(10):4602-11. PubMed ID: 9144472
[TBL] [Abstract][Full Text] [Related]
48. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling.
Hargreaves RG; Borthwick NJ; Gilardini Montani MS; Piccolella E; Carmichael P; Lechler RI; Akbar AN; Lombardi G
J Immunol; 1997 Apr; 158(7):3099-107. PubMed ID: 9120262
[TBL] [Abstract][Full Text] [Related]
49. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
Siegel RM; Chan FK; Chun HJ; Lenardo MJ
Nat Immunol; 2000 Dec; 1(6):469-74. PubMed ID: 11101867
[TBL] [Abstract][Full Text] [Related]
50. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
[TBL] [Abstract][Full Text] [Related]
51. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1).
Zuliani C; Kleber S; Klussmann S; Wenger T; Kenzelmann M; Schreglmann N; Martinez A; del Rio JA; Soriano E; Vodrazka P; Kuner R; Groene HJ; Herr I; Krammer PH; Martin-Villalba A
Cell Death Differ; 2006 Jan; 13(1):31-40. PubMed ID: 16003386
[TBL] [Abstract][Full Text] [Related]
52. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
Kajiwara K; Saito A; Ogata S; Tanihara M
Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
[TBL] [Abstract][Full Text] [Related]
53. TRAIL/Apo-2-ligand-induced apoptosis in human T cells.
Jeremias I; Herr I; Boehler T; Debatin KM
Eur J Immunol; 1998 Jan; 28(1):143-52. PubMed ID: 9485194
[TBL] [Abstract][Full Text] [Related]
54. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
55. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.
Holmström TH; Schmitz I; Söderström TS; Poukkula M; Johnson VL; Chow SC; Krammer PH; Eriksson JE
EMBO J; 2000 Oct; 19(20):5418-28. PubMed ID: 11032809
[TBL] [Abstract][Full Text] [Related]
56. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
57. Insights into the molecular regulation of FasL (CD178) biology.
Lettau M; Paulsen M; Schmidt H; Janssen O
Eur J Cell Biol; 2011; 90(6-7):456-66. PubMed ID: 21126798
[TBL] [Abstract][Full Text] [Related]
58. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.
Schneider P; Holler N; Bodmer JL; Hahne M; Frei K; Fontana A; Tschopp J
J Exp Med; 1998 Apr; 187(8):1205-13. PubMed ID: 9547332
[TBL] [Abstract][Full Text] [Related]
59. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
60. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Piccoli M; Frati L; Santoni A
J Immunol; 2005 Jan; 174(1):223-32. PubMed ID: 15611244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]